Endovascular Repair of Abdominal Aortic Aneurysm Endovascular Repair of Abdominal Aortic Aneurysm
How might endovascular aneurysm repair benefit patients with abdominal aortic aneurysm who are physically frail and ineligible for open repair?Annals of Surgery (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 15, 2017 Category: Consumer Health News Tags: General Surgery Journal Article Source Type: news
Endovascular Repair of Ruptured AAA Improves Midterm Survival Endovascular Repair of Ruptured AAA Improves Midterm Survival
Endovascular repair of ruptured abdominal aortic aneurysm was linked to reduced mortality at 3 years, improved early quality of life, and reduced costs compared with open surgery in the IMPROVE trial.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 20, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news
Abdominal Aortic Aneurysm (Symptoms, Repair, Surgery, Survival Rate)
Title: Abdominal Aortic Aneurysm (Symptoms, Repair, Surgery, Survival Rate)Category: Diseases and ConditionsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 11/15/2017 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - November 15, 2017 Category: Cardiology Source Type: news
This Device Has Been Around for 20 Years
It comes in different sizes and configurations now, but the Gore Excluder AAA Endoprosthesis, which seals off abdominal aneurysms from inside the aorta, hasn’t changed radically since it was introduced to the European market in 1997.
The endovascular aneurysm repair (EVAR) device has been implanted in more than 300,000 patients diagnosed with an abdominal aortic aneurysm (AAA), according to its manufacturer, W.L. Gore & Associates. Before EVAR, patients with AAA had two options: major surgery to repair the aneurysm or crossed fingers.
“The number of patients who were not candidates for surgery really drove the earl...
Source: MDDI - October 13, 2017 Category: Medical Devices Authors: Nancy Crotti Tags: Implants Design Source Type: news
Endologix touts Japanese collab dev & distro deal, 1st-in-human Ovation Alto trial data
Endologix (NSDQ:ELGX) this week announced a joint R&D and exclusive distribution deal with Japan Lifeline and released case review results from the 1st-in-human use of its Ovation Alto stent graft designed for endovascular aneurysm repair.
The Irvine, Calif.-based company said it inked a deal with Japan Lifeline to jointly invest in development, clinical research and commercialization of novel endovascular stent graft systems for the treatment of thoracic aortic disease.
Japan Lifeline will gain exclusive distribution rights to the systems in Japan, while Endologix said it will commercialize the system through its exi...
Source: Mass Device - September 14, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Clinical Trials Distribution Research & Development Stents Vascular Endologix Source Type: news
UCLA Health hospitals place No. 1 in Los Angeles, No. 7 nationally in prominent ranking
UCLA Health hospitals in Westwood and Santa Monica placed No. 1 in Los Angeles, No. 2 in California and No. 7 in the nation in the 2017 –18 U.S. News and World Report rankings.“UCLA Health is proud to be recognized for providing world-class treatment to patients from greater Los Angeles, across the state and around the globe,” said Johnese Spisso, president ofUCLA Health, CEO of UCLA Hospital System and associate vice chancellor of UCLA Health Sciences. “Our long-standing commitment to excellence ensures that our patients and their families receive the most compassionate, comprehensive care possible from every memb...
Source: UCLA Newsroom: Health Sciences - August 8, 2017 Category: Universities & Medical Training Source Type: news
MassDevice.com +5 | The top 5 medtech stories for April 26, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. Baxter sees shares lift on Street-beating Q1 earnings release
Baxter shares have risen today after the medical device company topped expectations on Wall Street with its 1st quarter earnings results.
The Deerfield, Ill.-based c...
Source: Mass Device - April 26, 2017 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news
Medtronic touts 5-year Endurant II AAA registry data
Medtronic (NYSE:MDT) today released 5-year data from the Engage global registry study of its Endurant II abdominal aortic aneurysm stent graft, touting long-term durability and consistent outcomes with the device.
Results from the study, which the company claims is the most robust post-market registry of endovascular aortic repairs to date, was presented at the 2017 Charing Cross Symposium in London this week.
“Medtronic aims to increase access to treatment for patients with aortic disease. This goal has been reinforced by our commitment to developing robust clinical programs – such as the Engage registry ̵...
Source: Mass Device - April 26, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Clinical Trials Endoscopic / Arthroscopic Stent Grafts Vascular Medtronic Source Type: news
Smokers have higher lifetime risk of abdominal aortic aneurysm
This study adds to the literature by reporting AAA lifetime risk from a community-based cohort with long follow-up,” Tang told Reuters Health by email.
The researchers used data from more than 15,000 middle-aged people who were at risk of developing AAA based on an initial assessment between 1987 and 1989. The participants made three subsequent visits for exams and assessments through 1998.
Nearly 6,000 people were still alive between 2011 and 2013 and underwent an ultrasound exam at a fifth assessment visit then.
Over the 22-year follow-up period, there were 590 diagnosed, ruptured or repaired AAAs. In 2011, the ultraso...
Source: Mass Device - November 17, 2016 Category: Medical Equipment Authors: MassDevice Tags: Vascular Source Type: news
The Ethics of Treating Patients in Pain
Discussion
On the surface this call may appear to be a simple back strain or a potential drug seeker. There are multiple points to be considered.
First, we should always consider our patients to be critical and let them prove us wrong. In other words, rather than seeing this patient as having just a back problem or seeking drugs, life-threatening conditions such as an abdominal aneurysm must be considered.
A thorough evaluation should be completed to help determine the cause of the pain. When the exact cause of pain isn't identifiable in the prehospital setting, treatment should focus on symptoms. This patient doesn't...
Source: JEMS Patient Care - November 1, 2016 Category: Emergency Medicine Authors: Dennis Edgerly, EMT-P Tags: Columns Patient Care Source Type: news
Follow-Up Essential After Endovascular AAA Repair Follow-Up Essential After Endovascular AAA Repair
Compared to an open approach, endovascular repair (EVAR) of abdominal aortic aneurysm (AAA) offers early survival benefit but shows inferior late survival, according to UK researchers.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - October 31, 2016 Category: Radiology Tags: Neurology & Neurosurgery News Source Type: news
Does Adding Epidural to General Anesthesia Improve Survival in AAA Repair? Does Adding Epidural to General Anesthesia Improve Survival in AAA Repair?
Combining epidural and general anesthesia for abdominal aortic aneurysm repair is associated with improved survival and lower risk of complications, according to a recent study. But the associations may not hold up in the real world, other researchers suggest.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - September 19, 2016 Category: Surgery Tags: Emergency Medicine News Source Type: news
InSeal Medical wins CE Mark for vascular closure device
InSeal Medical said today it won CE Mark approval in the European Union for its InClosure vascular closure device designed to close large bore arterial punctures.
The device is implanted percutaneously and requires no pre-procedure or sheath exchange and features a biodegradable membrane which is coupled to the vessel wall by a thin Nitinol frame, the Israel-based company said.
“The InClosure VCD significantly simplified large bore puncture closure which is still one of the last major challenges in TAVR. Based on our growing experience, the InClosure VCD allows for a smoother and safer TAVR procedure without pre-pro...
Source: Mass Device - August 8, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Cardiovascular Catheters Regulatory/Compliance InSeal Medical Ltd. Source Type: news
Duke again among top ranked U.S. hospitals
Treatment TermsCancerChildren's healthDigestive disordersEndocrinologyEye careGeriatric medicineHeartInflammatory and immune disordersLung diseaseCOPDNeurological disordersObstetrics and gynecologyOrthopaedicsGeriatricsSpineUrologyNeurosurgery
SEO Meta Description
Duke University Hospital in Durham, NC is once again ranked among the nation ’s best hospitals in U.S. News& World Report ’s 2016-2017 Best Hospitals Honor Roll.
Author
Debbe Geiger
Overview
Duke University Hospital in Durham, NC is once again ranked among the nation ’s best hospitals in<a href="http://health.usnews.com/best-hos...
Source: dukehealth.org: Duke Health News - August 2, 2016 Category: Consumer Health News Authors: dg62 at duke.edu Source Type: news
UCLA Health hospitals rank No. 1 in California and Los Angeles, No. 5 in U.S.
UCLA Health hospitals in Westwood and Santa Monica were ranked No. 1 in both Los Angeles and California and No. 5 in the nation in U.S. News and World Report’s annual honor roll.
The state and local rankings evaluate hospitals’ quality in nine relatively common procedures and treatments: abdominal aortic aneurysm repair, aortic valve surgery, chronic obstructive pulmonary disease, colon cancer surgery, care for congestive heart failure, heart bypass surgery, hip replacement, knee replacement and lung cancer surgery.
“By any measure, UCLA Health delivers the highest quality care available,” said Johnese Spisso, pres...
Source: UCLA Newsroom: Health Sciences - August 2, 2016 Category: Universities & Medical Training Source Type: news
